PATENT CLAIM ANALYSIS

Application Number: 16250212
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "303000"]

Abstract:
The purpose of the present invention is to provide novel compounds having ACC2 selective inhibitory activity. In addition, the present invention provides a pharmaceutical composition comprising the compound. A compound of Formula: or its pharmaceutically acceptable salt, wherein, R 1  is substituted or unsubstituted fused aromatic heterocyclyl represented by Formula: wherein,         ring B is 5-membered ring, ring C is 6-membered ring;           ring A is substituted or unsubstituted non-aromatic carbocycle or the like; -L 1 - is —O—(CR 6 R 7 )m- or the like; -L 2 - is —O—(CR 6 R 7 )n- or the like; each R 6  is independently hydrogen or the like; each R 7  is independently hydrogen or the like; each m is independently an integer of 0, 1, 2 or 3; each n is independently an integer of 1, 2 or 3; R 2  is substituted or unsubstituted alkyl; R 3  is hydrogen or substituted or unsubstituted alkyl; R 4  is substituted or unsubstituted alkylcarbonyl or the like.

Claim (Index 3):
The compound or its pharmaceutically acceptable salt according to  claim 2 , wherein X 5  is N(R x5 ), and X 6  is N.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 2.52632
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15557992', '15029031', '16176097', '15501749', '15741875']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8214940028145704
- 35 USC 102 Novelty (BERT): 0.5864837347949444
- Combined Prediction Score: 0.7979929760126079
- Mean Citation Score: 405.67489000000006
- Max Citation Score: 503.35162
- Similarity Product: 436.4292180110514

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test